Cardio Diagnostics Holdings, Inc. Files 8-K
Ticker: CDIOW · Form: 8-K · Filed: Oct 15, 2025 · CIK: 1870144
| Field | Detail |
|---|---|
| Company | Cardio Diagnostics Holdings, Inc. (CDIOW) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-actions, financial-reporting
Related Tickers: CDIO
TL;DR
CDIO filed an 8-K on 10/15/25 for votes and financials. Nothing major revealed yet.
AI Summary
Cardio Diagnostics Holdings, Inc. filed an 8-K on October 15, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, formerly known as Mana Capital Acquisition Corp. until June 29, 2021, is incorporated in Delaware and headquartered in Chicago, IL.
Why It Matters
This filing indicates that Cardio Diagnostics Holdings, Inc. is providing updates on corporate actions and financial reporting to the SEC, which is standard procedure for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting standard corporate events and financial statements, not indicating any immediate material changes or risks.
Key Players & Entities
- Cardio Diagnostics Holdings, Inc. (company) — Registrant
- Mana Capital Acquisition Corp. (company) — Former company name
- October 15, 2025 (date) — Date of Report
- June 29, 2021 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- Chicago, IL (location) — Business address city and state
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What financial statements are being reported?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in the provided text.
When did Cardio Diagnostics Holdings, Inc. change its name from Mana Capital Acquisition Corp.?
The company changed its name from Mana Capital Acquisition Corp. on June 29, 2021.
Where is Cardio Diagnostics Holdings, Inc. headquartered?
The company's business address is listed as 311 W. Superior Street, Suite 444, Chicago, IL 60645.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Stats: 814 words · 3 min read · ~3 pages · Grade level 12.2 · Accepted 2025-10-15 16:45:25
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 CDIO The Nasdaq Stock Market LLC
Filing Documents
- cdio_8k.htm (8-K) — 42KB
- 0001079973-25-001612.txt ( ) — 252KB
- cdio-20251015.xsd (EX-101.SCH) — 4KB
- cdio-20251015_def.xml (EX-101.DEF) — 26KB
- cdio-20251015_lab.xml (EX-101.LAB) — 36KB
- cdio-20251015_pre.xml (EX-101.PRE) — 25KB
- cdio_8k_htm.xml (XML) — 6KB
07
Item 5.07. Submission of Matters to a Vote of Security Holders. On October 15, 2025, Cardio Diagnostics Holdings, Inc., a Delaware corporation (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). Of the Company's 1,763,129 shares of common stock issued and outstanding and eligible to vote as of the record date of August 25, 2025, a total of 927,526 shares, or approximately 52.6% of the eligible shares, was in attendance or represented by proxy. The Company's stockholders voted on three proposals as set forth below. Each of the proposals is described in further detail in the Company's definitive proxy statement, which was filed with the Securities and Exchange Commission on September 4, 2025. The final voting results, including the number of votes cast for, against, or withholding authority, and the number of abstentions and any broker non-votes, with respect to each matter voted upon are set forth below, as reported by the Company's independent inspector of election. Proposal 1: Election of Directors (the "Election of Directors Proposal") The Company's stockholders elected seven directors to serve for the ensuing year and until their successors are elected and qualified, or until their earlier death, resignation or removal. The Company elects its directors on a plurality vote basis. The votes regarding the election of directors were as follows: Nominee For Authority Withheld Broker Non-Votes Meeshanthini V. Dogan 361,246 103,733 462,547 Warren Hosseinion 429,765 35,214 462,547 Wendy J. Betts 355,919 109,060 462,547 Paul F. Burton 428,090 36,889 462,547 Peter K. Fung 433,252 31,727 462,547 James Intrater 427,266 37,713 462,547 Robert Philibert 431,160 33,819 462,547 Proposal 2: Approval of the future issuance of shares of Common Stock and/or securities convertible into or exercisable for Common Stock equal to 20% or more of the Common Stock outstanding in one or more non-public transactions as
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 15, 2025 CARDIO DIAGNOSTICS HOLDINGS INC. By: /s/ Elisa Luqman Elisa Luqman Chief Financial Officer